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The 23rd World Scout Jamboree in 2015 took place in 
Japan and included over 33,000 scouts from 162 coun-
tries. Within nine days of the meeting ending, six cases 
of laboratory-confirmed invasive serogroup W menin-
gococcal disease occurred among scouts and their 
close contacts in Scotland and Sweden. The isolates 
responsible were identical to one-another by routine 
typing and, where known (4 isolates), belonged to the 
ST-11 clonal complex (cc11) which is associated with 
large outbreaks and high case fatality rates. Recent 
studies have demonstrated the need for high-reso-
lution genomic typing schemes to assign serogroup 
W cc11 isolates to several distinct strains circulating 
globally over the past two decades. Here we used such 
schemes to confirm that the Jamboree-associated 
cases constituted a genuine outbreak and that this was 
due to a novel and rapidly expanding strain descended 
from the strain that has recently expanded in South 
America and the United Kingdom. We also identify the 
genetic differences that define the novel strain includ-
ing four point mutations and three putative recombi-
nation events involving the horizontal exchange of 17, 
six and two genes, respectively. Noteworthy outcomes 
of these changes were antigenic shifts and the disrup-
tion of a transcriptional regulator.
Introduction
Neisseria meningitidis is a leading cause of meningitis 
and septicaemia [1]. Occurrences of invasive menin-
gococcal disease (IMD) range from sporadic cases to 
large outbreaks and epidemics. Outbreaks have been 
associated with mass gatherings such as that of the 
annual Hajj pilgrimage to Mecca [2]. The 23rd World 
Scout Jamboree took place between 28 July and 8 
August 2015 in Japan and included 33,000 scouts from 
162 countries [3]. Over the nine days that followed, 
three scouts and one non-attending close contact of a 
healthy scout from the North of Scotland Unit, and two 
scouts from the Stockholm Unit (Sweden), fell ill with 
laboratory-confirmed IMD.
All of the patients were admitted to hospital. One of 
the cases presented with meningitis and shock and 
was treated in intensive care for six days. The remain-
ing five cases exhibited relatively mild non-specific 
and/or atypical (respiratory) symptoms. All cases even-
tually recovered well with no apparent sequelae [3]. A 
further seven suspected cases among attendees (five 
in Scotland and two in Sweden, the latter of which 
represented two further distinct scout units) were 
eventually discounted. In the course of the outbreak 
management, chemoprophylaxis was administered to 
53 Scottish scouts, leaders and close contacts, and a 
further individual outside of Scotland. All of them were 
also offered quadrivalent ACWY conjugate vaccine [4]. 
In Sweden, where the outbreak initially appeared more 
diffuse, chemoprophylaxis was offered to all 1,900 
Jamboree participants, with an uptake of ca 80% (data 
not shown). This was accompanied by throat swabbing 
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to assess the meningococcal carriage rate during the 
outbreak.
Invasive meningococcal isolates (from sterile sites) 
were obtained from each of the Scottish cases and 
one of the Swedish cases. The other Swedish case 
yielded a throat swab isolate and was confirmed as 
a case serologically by a complement binding assay 
exhibiting cross-reactivity against N. meningitidis and 
N. gonorrhoeae. The six meningococcal isolates were 
indistinguishable in terms of serogroup and PorA sub-
type (serogroup W, PorA subtype P1.5,2,36–2). The four 
Figure 1
Population structure of the South American W:cc11 strain sublineage
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Neighbour-net phylogenetic network based on a comparison of 1,546 core genome loci among all South American W:cc11 strain sublineage 
genomes (n = 454; accessed on 21 January 2016) on the PubMLST database. A single serogroup B lineage 11.2 genome (M09 240026) was used 
to represent the remainder of cc11 (‘to remainder of cc11’). The sublineage was divided into three main strains, the South American strain, the 
original United Kingdom (UK) strain that emerged in the UK in 2009, and the novel ‘2013-strain’ that emerged in the UK in 2013. The scale bar 
indicates the number of differences among the 1,546 loci compared.
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Scottish isolates also underwent FetA and multilocus 
sequence typing (MLST) and, again, were identical to 
one another (FetA F1–1 and sequence type (ST)-11) [3]. 
ST-11 is part of the ST-11 clonal complex (cc11) which 
is associated with multiple serogroups, a tendency to 
cause outbreaks and epidemics, atypical clinical pres-
entations, and relatively high case fatality rates [5]. 
Serogroup C cc11, for example, has caused outbreaks 
among military recruits [6], university undergraduates 
[7] and more recently, men who have sex with men [8]. 
Serogroup W cc11 (W:cc11), meanwhile, was responsi-
ble for the global Hajj-associated outbreak in 2000 [2], 
followed by several large epidemics in sub-Saharan 
Africa recently reviewed by Mustapha et al. [9], and 
the expansion of endemic disease in South Africa [10], 
South America [11] and Europe [12].
As with the recent scout cases, the vast majority of 
W:cc11 isolates from each of the above episodes are 
indistinguishable using routine typing schemes (up 
to and including the level of MLST) [13]. As a conse-
quence, the organisms responsible have collectively 
been described as the ‘Hajj strain’, denoting the first 
large outbreak characterised as such. Relatively high-
resolution techniques such as pulsed-field gel elec-
trophoresis, however, were indicative of underlying 
diversity [14]. More recently, genome-level compari-
sons have indicated that almost all W:cc11 isolates 
belong to cc11 lineage 11.1, one of two divergent cc11 
lineages. Furthermore, W:cc11 isolates correspond-
ing to the major W:cc11 outbreaks were resolved into 
distinct clusters (strains) within two divergent line-
age 11.1 sublineages [13]. The Hajj strain sublineage 
comprises the W:cc11 Hajj outbreak strain, sub-Saha-
ran African W:cc11 strains from epidemic periods, and 
the recent endemic South African W:cc11 strain. The 
South American W:cc11 strain sublineage (previously 
designated the ‘South American/United Kingdom (UK) 
strain’) charts the diversification of the South American 
strain and closely related UK strain during expansion 
from southern Brazil, through Argentina and Chile and 
onto the UK and Europe. Each distinct strain represents 
clonal expansion from a single ancestor and may be 
defined by the genetic differences that distinguish it 
from closely related strains.
The current study sought to determine (i) which of the 
Jamboree-associated cases represented a genuine 
outbreak, (ii) to identify the strain/s responsible and 
its/their relationship to other geo-temporally diverse 
W:cc11 isolates, (iii) to chart its/their carriage among 
the Swedish returnees, and (iv) to identify its defining 
genomic characteristics.
Methods
Genomes
The study used all W:cc11 genomes on the PubMLST 
Neisseria database [15] (n = 873; accessed 21/01/16). 
These included the Scottish (n = 4) and Swedish (n = 2) 
outbreak isolates and carrier isolates from Swedish 
Jamboree attendees (n = 10). The latter 16 isolates are 
hereafter referred to as the ‘Jamboree-associated’ iso-
lates. The W:cc11 panel also included genomes from 
earlier Scottish (2015, n = 11; 2013, n = 1; and 2012, 
n = 1) and Swedish (2015, n = 6) cases. A separate sub-
set of sero/genogroup B, C and W cc11 genomes were 
used as a representative panel spanning the known 
diversity of cc11 (n = 106; Box) [13].
Genomic analyses
Genome comparisons were performed using the 
PubMLST genome comparator tool [16]. In order to 
map their diversity on a ‘macro’ scale, all of the W:cc11 
genomes (n = 873) were initially split into two man-
ageable groups and each group, along with the repre-
sentative panel spanning the known diversity of cc11, 
underwent genome comparisons in terms of every 50th 
core gene (numerically) starting with BACT000001. 
Refined analyses of the population comprising the 
Jamboree-associated and related genomes were per-
formed using 1,546 core genome loci [12]. Genetic 
differences defining the Jamboree-associated and 
related genomes were identified by comparing these 
and related genomes in terms of all corresponding 
indexed ‘neis’ loci on the PubMLST Neisseria database. 
Resulting distance matrices were visualised using 
SplitsTree4 [17].
Results
In initial comparisons (using 52 core genes) including 
a panel of isolates representing the known diversity 
of cc11, the Jamboree-associated isolates were found 
Figure 2
Cases of culture-confirmed invasive meningococcal 
disease caused by the original United Kingdom strain 
and 2013-strain of the South American W:cc11 strain 
sublineage, by year, England, Wales and Northern Ireland, 
2009–2015 (n = 349)
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The chart includes five isolates from pre-Meningococcus Genome 
Library (2009: 2 and 2010: 3) and includes all corresponding 
isolates received by the Meningococcal Reference Unit up to 4 
November 2015.
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to cluster with isolates of the South American W:cc11 
strain sublineage (data not shown).
Figure 3
Population structure and geographical distribution of isolates belonging to the 2013-strain of the South American W:cc11 
strain sublineage
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Neighbour-net phylogenetic network based on a comparison of all corresponding indexed ‘neis’ loci among all W:cc11 2013-strain genomes 
(n = 169) on the PubMLST Neisseria database. A single original United Kingdom (UK) strain genome (M14 240001) was used to represent the 
original UK strain (To original UK strain). The Jamboree-associated isolates (four Scottish cases, two Swedish cases and 10 Swedish carriers) 
belonged to a distinct cluster – the Jamboree-associated cluster. The other isolates included case isolates from the UK (n = 144; unmarked), 
France (n = 3) and Sweden (n = 6), carrier isolates from the UK (n = 3), and a Finnish isolate of unknown status. The scale bar indicates the 
number of differences among all corresponding indexed ‘neis’ loci.
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A core genome comparison (1,546 loci) of all of the 
South American W:cc11 strain sublineage genomes 
revealed the existence of a novel strain alongside the 
previously described South American strain and origi-
nal UK strain that emerged in 2009 [13] (Figure 1).
The novel ‘2013-strain’ emerged in the UK in 2013 and 
included all of the Jamboree-associated isolates as 
well as additional invasive isolates from the UK (2013–
2015: 144), France (2015: 3) and Sweden (2015: 6). It 
also included three UK carrier isolates and a single 
Finnish isolate (2015) of unknown clinical status. UK 
cases due to the 2013-strain have approximately dou-
bled year-on-year since its emergence while the initially 
comparable rate of expansion of the original UK strain 
began to slow (Figure 2).
The 2013-strain isolates and a single original UK 
strain isolate (M14 240001) underwent a comprehen-
sive genome comparison in terms of all corresponding 
indexed ‘neis’ loci on the PubMLST Neisseria database. 
The Jamboree-associated isolates exclusively formed a 
distinct cluster within the 2013-strain (Figure 3).
Within the ‘Jamboree-associated cluster’ the Scottish 
case isolates and Swedish case/carrier isolates formed 
separate subclusters relatively close/distant to the ori-
gin of the main cluster, respectively.
All isolates belonging to the original UK and 2013-strains 
were compared in terms of all corresponding indexed 
‘neis’ loci, as above. The genome comparator output 
data were examined for common differences distin-
guishing the 2013-strain from the original UK strain. 
The transition included three putative recombination 
events involving 17, six and two genes, respectively, 
and four point mutations (Table).
Genes affected included those encoding antigens 
(including the haemoglobin-haptoglobin receptor com-
plex HpuAB), the genetic regulator MtrR, and a number 
of housekeeping/metabolic genes. In addition, the 
predominant csw (serogroup W determinant) genes 
of the respective strains differed by two compensa-
tory frameshift mutations. As one of these was in a 
homopolymer, it is uncertain whether these consti-
tuted spontaneous mutations or a small recombination 
event.
Allelic variants within the largest recombinant region 
(nmb0813 to 0829) ranged from being unique to 
the W:cc11 isolates (neis0813, neis0815, neis0819, 
neis0825 and neis0827 to 8) to being observed among 
isolates belonging to various ccs on the PubMLST data-
base. BLAST searches on the NCBI nt database failed 
to identify exact matches for the unique W:cc11 alleles. 
Four out of six alleles within the second largest recom-
binant region (neis1131 to neis1136) were also observed 
among multiple ccs. Of the remaining two, neis1131 was 
unique to the W:cc11 isolates. Only three non-cc11 iso-
lates within the database matched all five of the non-
unique alleles – isolate IDs 40007 and 40393 (both 
ST-10144; 1 invasive and 1 not specified) and isolate 
ID 20026 (ST-9880; invasive). The acquired hpuA and 
hpuB alleles were novel on both the PubMLST and nt 
databases.
Discussion
High resolution genomic analyses indicated that the 
Scottish and Swedish IMD cases associated with the 
23rd World Scout Jamboree constituted a genuine out-
break with transmission of meningococci belonging to 
a distinct phylogenetic cluster over a short period of 
time.
Isolates from Scottish cases were relatively closely 
related to one-another, probably reflecting prolonged 
intragroup contact. Isolates from the Swedish cases 
and carriers were similarly grouped but at a more distal 
location within the overall cluster, probably reflecting 
the spread of carriage among the wider Jamboree par-
ticipants and further group-wise propagation. Broader 
dissemination of organisms belonging to the cluster 
was evident from the Scottish case that occurred in 
a non-attending close contact. None of the 62 W:cc11 
submissions made to the PubMLST Neisseria database 
subsequent to the outbreak, including post-Jamboree 
cases from Sweden (2015: 2 and 2016: 7), the UK (2015: 
33), and France (2016: 11), have, however, belonged 
to the Jamboree-associated cluster (accessed 20 April 
2016; data not shown). Ongoing and retrospective 
genomic surveillance will determine whether the public 
health interventions employed in the respective coun-
tries have served to curtail onward transmission of 
organisms belonging to the outbreak cluster.
The Jamboree-associated cluster formed part of a novel 
strain, the proposed ‘2013-strain’, which emerged in 
the UK in 2013, with cases approximately doubling 
annually. This strain represented clonal expansion from 
a single descendant, or close relative, of the original 
UK strain which emerged in England in 2009 exhibiting 
Box
PubMLST Neisseria IDs of a panel of serogroup B, C and 
W cc11 genomes spanning the known diversity of cc11
19957, 29677, 29680, 29681, 29683, 21573, 21578, 21582, 
21583, 21584, 30087, 30088, 30089, 30090, 30092, 27087, 
29679, 29705, 30076, 30077, 19968, 20057, 20154, 20158, 
20196, 29633, 29580, 27089, 20066, 29631, 29976, 29664, 
21134, 21311, 21330, 26824, 27803, 26733, 26821, 29639, 
28103, 21208, 30295, 29571, 30060, 29908, 30284, 29789, 
1170, 29590, 29641, 644, 30296, 30244, 29840, 29849, 
29858, 29865, 314, 30239, 30240, 30241, 30243, 344, 
29611, 29626, 29638, 29891, 21335, 29578, 21196, 29643, 
665, 20261, 29831, 30257, 30261, 30260, 21587, 29315, 
29329, 29330, 29381, 29324, 29325, 29328, 29331, 29349, 
21581, 29334, 29340, 29341, 29366, 29648, 29649, 29651, 
29652, 29653, 29709, 29710, 30178, 30234, 30237, 29704, 
30183, 30184
Panel selected from [13].
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(initially) a similar rate of expansion. The expansion of 
serogroup W disease in Scotland became evident from 
2014 [18], however, the present study identified earlier 
cases caused by the original UK strain (2012: 1) and 
2013-strain (2013: 1), respectively. Prior to the case 
in 2012, Scotland experienced no W:cc11 cases for at 
least three years. After 2013, endemic Scottish W:cc11 
cases were distributed among both strains. Sweden 
experienced a greater than three-fold rise in W:cc11 
cases in 2015 mainly due to the 2013-strain (n = 7), with 
a single additional isolate from the Hajj strain subline-
age. The 2013-strain was also responsible for the only 
two Swedish W:cc11 cases in 2014 (data not shown). 
Prior to 2014, Sweden experienced one confirmed 
W:cc11 case per year dating back to 2010 (correspond-
ing strains unknown).
Despite cc11 having been associated with numerous 
focal outbreaks in the past [2,6,7], to our knowledge 
the original UK strain has only been associated with a 
single focal outbreak, namely two cases in a healthcare 
setting in the UK [12,19], with a further four suspected 
UK outbreaks discounted using the methods described 
herein (data not shown). The rapid expansion of 
Table
Common genetic differences distinguishing the 2013-strain from the original UK strain (grouped into putative 
recombinations where appropriate)
Genea MC58 identifierb Gene product Impactc
NEIS0813 NMB0872 Putative periplasmic protein None
NEIS0814 NMB0873 Outer membrane lipoprotein LolB 1 aa change
NEIS0815 NMB0874 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase 16 aa changes
NEIS0816 NMB0875 Ribose-phosphate pyrophosphokinase None
NEIS0817 NMB0876 50S ribosomal protein L25 (rplY ) None
NEIS0818 NMB0877 Putative D-alanyl-D-alanine carboxypeptidase 5 aa changes
NEIS0819 NMB0878 Threonine dehydratase 2 aa changes
NEIS0820 NMB0879 Putative sulphate permease ATP-binding protein 1 aa change
NEIS0821 NMB0880 Putative sulphate permease inner membrane protein 2 aa changes
NEIS0822 NMB0881 Sulphate permease inner membrane protein (cysU) 1 aa change
NEIS0823 NMB0882 Hypothetical protein 1 aa change
NEIS0824 NMB0883 Hypothetical protein 2 aa changes
NEIS0825 NMB0884 Superoxide dismutase (sodB) 2 aa changes
NEIS0826 NMB0885 Replicative DNA helicase 2 aa changes
NEIS0827 NMB0886 Type IV biogenesis protein (pilH) 5 aa changes
NEIS0828 NMB0887 Type IV biogenesis protein (pilI) 1 aa change
NEIS0829 NMB0888 Type IV biogenesis protein (pilJ) 2 aa changes
NEIS1131 NMB1231 Putative ATP-dependent protease 1 aa change
NEIS1132 NMB1232 Hypothetical protein In-frame gene acquiredd
NEIS1133 NMB1233 Exodeoxyribonuclease V alpha subunit 11 aa changes
NEIS1134 NMB1234 Putative ABC-transporter ATP-binding protein 7 aa changes
NEIS1135 NMB1235 Putative integral membrane protein 4 aa changes
NEIS1136 NMB1236 Hypothetical protein None
NEIS1351 NMB1418 Lipid A biosynthesis lauroyl acyltransferase (lpxL) 1 aa changee
NEIS1386 NMB1448 DNA polymerase IV 1 aa changee
NEIS1412 NMB1475 Hypothetical protein 1 aa changee
NEIS1635 NMB1717 Transcriptional regulator (mtrR) Frameshiftf
NEIS1946 NA Haemoglobin-haptoglobin utilisation protein (hpuA) 25 aa changesg
NEIS1947 NA Haemoglobin-haptoglobin utilisation protein (hpuB) 44 aa changes
NEIS2162 NA Glycosyltransferase (csw) 2 aa changesh
NA: not applicable; UK: United Kingdom.
a PubMLST Neisseria database identifier.
b MC58 strain identifier, GenBank accession number AE002098.2.
c Regarding predominant alleles for respective strains.
d Gene frameshifted in original UK strain.
e Single nt polymorphism.
f Single bp insertion.
g If homopolymer normalised and within frame.
h Two existing alleles; two compensatory frameshifts.
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2013-strain cases and a possible association with out-
breaks may represent heightened carriage, transmis-
sion, invasiveness or virulence of the novel strain, or 
indeed a combination of these factors. This change in 
epidemiology may, in turn, be a direct consequence of 
the genetic changes that define the strain. Studies of 
previous outbreaks/expansions have implicated anti-
genic shifts in prominent antigens such as PorA [20,21] 
or fHbp [22], owing to recombination events. As such, 
possible candidates among 29 altered genes within 
the 2013-strain include hpuA and hpuB (encoding the 
haemoglobin-haptoglobin receptor, HpuAB [23]) which 
underwent the greatest number of amino acid changes 
(25 and 44, respectively). Genes involved in the sur-
face expression of other proteins may also be impli-
cated such as the three genes involved in type IV pilus 
biogenesis (neis0827–8) [24]. Indeed, haemoglobin 
receptors and pili are not only major antigens but also 
important virulence factors. Interestingly, relatively 
remote genes involved in the translocation of lipopro-
teins to the outer membrane (neis0814, neis0815 and 
neis1134) were affected by two of the three putative 
recombination events.
The acquisition of a frameshifted mtrR allele may be 
significant. MtrR is a transcriptional regulator con-
cerned with the expression of various genes in N. 
gonorrhoeae, including those encoding multidrug 
efflux pumps and others involved in stress responses 
[25]. It has also been proposed that mutant (including 
frameshifted) mtrR alleles may be advantageous for 
N. gonorrhoeae during infection [25]. MtrR has also 
recently been implicated in the regulation of nadA 
expression in the meningococcus. NadA is a major sur-
face antigen and a virulence factor involved in adher-
ence and invasion [26,27]. It is also a component of the 
multicomponent vaccine developed to target serogroup 
B meningococci (Bexsero) and the likely target of cor-
responding protection that has been demonstrated 
against isolates of the original UK W:cc11 strain [28].
The involvement of the lpxL gene is noteworthy 
because this gene is involved in acylation of endotoxin. 
Frameshifts in lpxL have, for example, been implicated 
in milder disease [29] which was a feature among 
the Scottish cases but not the Swedish cases, one of 
whom required six days of intensive care [3]. In the 
course of routine serogrouping, no obvious effect was 
observed for the altered csw gene. The Public Health 
England serogrouping assay [30] would not, however, 
be expected to identify subtle qualitative/quantitative 
differences in capsule composition.
We were unable to identify potential donor strains 
involved in several of the putative recombinations and 
those that we did identify did not belong to common 
invasive lineages among countries regularly submitting 
genomic data to the NCBI nt or PubMLST Neisseria data-
bases. Other Neisseria species less well represented 
on the sequence databases also constitute potential 
donors [31]. The acquisition of relatively rare alleles, 
especially those relating to surface antigens may be 
advantageous owing to the naivety of the human host 
population. Genomic analyses of recent carriage stud-
ies may shed further light on the identity of the respec-
tive donor strains [32,33].
The exact cause of the expansion of the 2013-strain 
may never be known. Indeed, it may be that this strain 
has by chance encountered several environments con-
ducive to widespread transmission, such as universi-
ties and mass gatherings. Nonetheless, the current 
analyses revealed that that the continued expansion of 
W:cc11 in the UK is largely due to the 2013-strain while 
the expansion of the original UK strain appears to have 
slowed. Whether the 2013-strain is destined to fol-
low a similar course may also not be known since it is 
hoped that the recent introduction of the quadrivalent 
ACWY conjugate vaccine to UK adolescents, including 
new university entrants, will lead to wider herd pro-
tection [34]. Within the 2013-strain, the appearance of 
the Jamboree-associated cluster appears to have been 
transient. Should it re-emerge to expand in a way that 
is comparable to either the 2013- or original UK strains 
then further investigation may be warranted to identify 
its defining genetic changes.
The present study demonstrates the utilisation of 
genomic analysis, in conjunction with comprehensive 
geo-temporally diverse genomes, to identify bacterial 
outbreak strains within highly clonal populations. It 
also demonstrates how such studies may shed light on 
the emergence of outbreak strains, inform immunisa-
tion policy, and, perhaps, inform the development of 
new vaccines and even therapeutics.
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